Home › Funds › Tandem Investment Advisors, Inc. › JNJ

Tandem Investment Advisors, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Tandem Investment Advisors, Inc. reported holding 111,101 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$29.4M, representing 2.20% of its reported portfolio and ranking #20 among its reported holdings. Tandem Investment Advisors, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)111.10K sh
Reported value held$29.41M
Portfolio Weight2.20%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tandem Investment Advisors, Inc.'s JNJ position evolved

Tandem Investment Advisors, Inc. first disclosed a stake in JNJ in Q3 2023 at 485,131 shares (US$75.6M). The position peaked in Q3 2024 at 505,100 shares, worth US$81.9M. Across 13 filings, Tandem Investment Advisors, Inc. increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 111,101 shares valued at US$29.4M — a reduction of -25,097 shares quarter over quarter.. Notable position changes include a 41% trim in Q1 2025 (shares fell 6% over the following quarter), a 34% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 485.13K $75.56M New
Q4 2023 477.17K $74.79M Reduce
Q1 2024 496.92K $78.61M Add
Q2 2024 505.51K $73.89M Add
Q3 2024 505.10K $81.86M Hold
Q4 2024 500.88K $72.44M Reduce
Q1 2025 293.81K $48.73M Reduce
Q2 2025 289.66K $44.25M Reduce
Q3 2025 281.90K $52.27M Reduce
Q4 2025 268.61K $55.59M Reduce
Q1 2026 176.60K $43.17M Reduce
Q2 2026 136.20K $34.59M Reduce
Q3 2026 111.10K $29.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Tandem Investment Advisors, Inc. held JNJ?

Tandem Investment Advisors, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tandem Investment Advisors, Inc.'s current position in JNJ?

As of Q3 2026, Tandem Investment Advisors, Inc. holds 111.10K shares of JNJ (JOHNSON & JOHNSON), valued at $29.41M, representing 2.20% of its reported portfolio and ranking #20.

Has Tandem Investment Advisors, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Tandem Investment Advisors, Inc. reduced its position in JNJ. The position peaked in Q3 2024 at 505.10K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.